Is PGEN a good stock to buy? We came across a bullish thesis on Precigen, Inc. on Valueinvestorsclub.com by coalone. In this article, we will summarize the bulls’ thesis on PGEN. Precigen, Inc.'s share was trading at $4.0200 as of April 28th. PGEN’s forward P/E was 9.14 according to Yahoo Finance.
[caption id="attachment_564437" align="aligncenter" width="750"]Precigen (PGEN) is a biotechnology company that has transitioned from a clinical-stage developer to a commercial rare disease platform following the August 2025 approval of...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.